Bevacizumab ELISA Kit (DB941018)

Vista general

Número de catálogo	DB941018
Descripción	Bevacizumab ELISA Kit (DB941018) — Quantitative sandwich ELISA for Bevacizumab. Sample: Plasma, Serum. Range: 312.5 - 20, 000 ng/mL. Sensitivity: 98.1 ng/mL. Highlights ●Sandwich Format — High specificity, reliable quantification. ●High Sensitivity — Optimized for low-abundance target detection. ●Ready-to-Use — Complete kit with pre-coated plates included.
Tipo de muestra	Plasma, Serum
Sensibilidad	98.1 ng/mL
Rango	312.5 - 20, 000 ng/mL
Número de acceso	P15692
Aplicaciones	ELISA
Método de detección	Colorimetric
Tipo de ensayo	Quantitative
Recuperación	80-120%
Envío	2-8 ℃
Estabilidad y almacenamiento	When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20℃, the rest reagents should be store at 4℃.
Especificaciones	Bevacizumab
Nombres alternativos	12-IgG1, F(ab)-12 IgG1, Fab-12 IgG1, rhuMAb-VEGF, ABP 215, 216974-75-3
Fondo	Vascular endothelial growth factor A, long form (Bevacizumab) is a ~43 kDa protein. Participates in the induction of key genes involved in the response to hypoxia and in the induction of angiogenesis such as HIF1A. Involved in protecting cells from hypoxia-mediated cell death. 1. Katsman, M. et al. (2022) Cells 11. PMID: 35455969
Nota	For Research Use Only.